Trevi Therapeutics Inc (TRVI) Financials

$15.90

$-0.01 (-0.06%)

As on 11-Sep-2026 16:00EDT

Market cap

$2,459 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

7.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.07	0.13	0.15	0.12	0.04	0.05
Gross Profit	-0.07	-0.13	-0.15	-0.12	-0.04	-0.05
Operating Expenses	59.56	49.33	51.52	33.92	29.91	32.48
Operating Profit (EBIT)	-59.56	-49.33	-51.52	-33.92	-29.91	-32.48
Other Income	--	--	--	--	0.14	--
Profit before Tax	-51.18	-42.82	-47.94	-29.10	-29.19	-33.96
Provision for Tax	-0.07	-0.06	-0.03	-0.03	-0.04	-0.02
Profit after Tax (Net Income)	-51.11	-42.76	-47.91	-29.07	-29.15	-33.94
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-29.15	-33.94

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	321.51	183.24	99.64	82.55	107.46	17.08
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.28	0.45	0.75	1.03	2.16	8.68
Current Liabilities	8.74	9.75	10.51	5.82	13.40	12.72
Total Liabilities	339.25	193.44	110.90	89.40	123.02	38.48

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	4.81	1.78	1.47	1.86	0.40	0.52
Current Assets	325.71	191.66	109.43	87.55	122.62	37.96
Total Assets	339.25	193.44	110.90	89.40	123.02	38.48
Total Debt*	0.61	0.75	1.03	1.34	9.18	14.63
Net Current Assets	316.97	181.91	98.92	81.72	109.22	25.23

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-42.09	-38.26	-31.71	-28.18	-28.95
Cash Flow from Investing Activities	--	-94.11	-21.53	59.43	-107.37	-107.37
Cash from Financing Activities	--	121.01	61.48	-7.91	111.31	20.78
Net Cash Inflow / Outflow	--	--	--	--	-24.24	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.35	-0.32	-0.47	-0.29	-0.45	-1.48
Cash EPS ($)	--	-0.32	-0.47	-0.29	-0.45	-1.47
Adjusted Book Value ($)	--	1.36	0.98	0.83	1.65	0.74
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.31	-0.38	-0.32	-0.43	-1.26
Free Cash Flow per Share ($)	--	-0.31	-0.38	-0.32	-0.44	-1.26

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-30.04	-51.92	-28.99	-39.30	-92.67
ROE (%)	-20.25	-30.23	-52.59	-30.59	-46.82	-153.03
ROA (%)	-18.36	-28.10	-47.84	-27.37	-36.10	-79.29
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-20,529.58	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	29.53	10.67	-66.99	4.02	8.71	-0.83
Net Profit Growth (%)	-8.05	10.75	-64.84	0.30	14.11	-3.61
EPS Growth (%)	18.47	0.33	-0.60	0.35	0.70	0.19
Book Value Growth (%)	34.12	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-39.53	-8.77	-4.56	-4.30	-0.53
Price / Book Value	7.56	9.22	4.22	1.61	1.17	1.05
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-4.92	-35.21	-6.56	-1.79	-0.47	0.13
Close Price ($)	18.65	12.52	4.12	1.34	1.93	0.78
High Price ($)	19.26	14.39	4.68	3.50	4.68	3.64
Low Price ($)	5.47	3.47	1.27	0.97	0.46	0.66
Market Cap ($ Cr)	2,459.13	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.00	0.01	0.02	0.09	0.86
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.07	0.35
Current Ratio	37.28	19.66	10.41	15.03	9.15	2.98
Quick Ratio	37.28	--	--	--	--	3.00
Interest Coverage	--	--	-11,984.25	-73.42	-38.34	-27.25

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	-2,047.10	2,388.74
Payable days	--	10,134.30	6,488.78	6,927.87	24,233.91	17,769.41
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.